Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model

Relapsed osteosarcoma is a recalcitrant tumor. A patient's cisplatinum (CDDP)-resistant relapsed osteosarcoma lung metastasis was previously established orthotopically in the distal femur of mice to establish a patient-derived orthotopic xenograft (PDOX) model. In the present study, the PDOX mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Kentaro, Kawaguchi, Kei, Kiyuna, Tasuku, Miyake, Kentaro, Miyake, Masuyo, Li, Yunfeng, Nelson, Scott D., Dry, Sarah M., Singh, Arun S., Elliott, Irmina A., Russell, Tara A., Eckardt, Mark A., Yamamoto, Norio, Hayashi, Katsuhiro, Kimura, Hiroaki, Miwa, Shinji, Tsuchiya, Hiroyuki, Eilber, Fritz C., Hoffman, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814257/
https://www.ncbi.nlm.nih.gov/pubmed/29487690
http://dx.doi.org/10.18632/oncotarget.22892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814257/
https://www.ncbi.nlm.nih.gov/pubmed/29487690
http://dx.doi.org/10.18632/oncotarget.22892

Ejemplares similares